<DOC>
	<DOCNO>NCT01835262</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy subdissociative dose intravenous ketamine compare intravenous morphine relieve acute pain ED . Secondary objective include rate adverse effect need rescue analgesia . The hypothesis intravenous administration subdissociative dose ketamine 0.3 mg/kg superior intravenous morphine 0.1mg/kg treat moderate severe acute pain patient present ED .</brief_summary>
	<brief_title>Low Dose Ketamine Versus Morphine Moderate Severe Pain Emergency Department</brief_title>
	<detailed_description>Rationale : Opioids traditionally accept cornerstone acute pain management Emergency Department ( ED ) . Morphine one commonly used parenteral opioid analgesic whose initial dose 0.1 mg/kg extensively research recommend control severe acute pain ED . However , intravenous administration opioids associate thefollowing side effect : hypotension , respiratory depression , dizziness , pruritis nausea . In addition , patient pre-existing renal and/or hepatic insufficiency , effect may pronounce require intervention . Thus , administration equipotent analgesic cause hypotension respiratory depression would enhance patient safety ED . Ketamine noncompetitive N-methyl D-aspartate ( NMDA ) receptor antagonist block release excitatory neurotransmitter glutamate provide anesthesia , amnesia analgesia virtue decrease central sensitization `` wind-up '' phenomenon . Due high lipid solubility , ketamine rapidly cross blood-brain barrier , provide rapid onset action ( peak concentration reach 1 minute IVP ) rapid recovery baseline ( duration action 5-15 minute IVP ) ( 1 ) . When give subdissociative dos 0.1-0.5 mg/kg , either adjunct opioid analgesic solo agent , ketamine provide good analgesia preserve airway patency , ventilation , cardiovascular stability ( 2 ) . In addition , small dose ketamine may increase analgesic potency opioids thus decrease dose requirement ( 3 ) . Based aforementioned fact , ketamine offer attractive option provide safe convenient pain control patient ED . A double-blind trial 40 adult patient acute musculoskeletal trauma compare low-dose ketamine administer subcutaneous infusion ( 0.1 mg/kg/h ) intermittent intravenous morphine ( 0.1 mg/kg IV every 4 hour ) demonstrate good pain relief , less sedation less nausea vomit ketamine infusion intermittent morphine . In addition , none patient ketamine group require supplementary analgesia ( 4 ) . A prospective , randomized trial compare two analgesic regimen , morphine ketamine ( K group ) morphine placebo ( P group ) severe acute pain 73 trauma patient visual analog scale ( VAS ) score least 60/100 . Morphine administer 0.1mg/kg ; patient K group receive 0.2 mg/kg intravenous ketamine 10 minute patient P group receive isotonic sodium chloride solution . The result show comparable change VAS score 30 minute ( 34 mm ( K ) vs. 39 mm ( P ) ) reduce morphine consumption ketamine group ( 0.14 mg/kg ( K ) vs 0.2 mg/kg ( P ) ) ( 5 ) . A chart review analysis 35 ED patient receive low dose ketamine dose 0.1mg-0.6mg/kg addition intravenous morphine demonstrate decrease pain intensity 54 % patient document 3 point pain decrease 10-point scale . The ketamine dose range 5 mg 35 mg median dose 10 mg mean dose 15.7mg . In addition , one patient brief dysphoric reaction require intervention ( 6 ) . Hypothesis : Intravenous administration subdissociative dose ketamine 0.3 mg/kg superior intravenous morphine 0.1 mg/kg treat moderate severe acute pain patient present ED . Methods : Prospective , randomize , double-blind trial evaluate compare analgesic effect intravenous Ketamine administer sub-dissociative dos : 0.3 mg/kg give 10 minute intravenous Morphine give 0.1mg/kg single IVP . Description : Once patient triaged , initial pain score assess patient 's state weight record chart . Patients initial evaluation attend ED physician find eligible study ( deem treat physician warrant administration intravenous analgesia ) patient randomize receive either morphine 0.1 mg /kg give IVP ketamine 0.3 mg/given IVP . Patients ' vital sign record triage , begin study 15 , 30 , 60 , 90 , 120 minute post-administration . Patients place monitor continuous pulse oximetry ( oxygen saturation ) , blood pressure , heart rate respiratory rate record . We compare efficacy difference 2 group pain relief baseline ( triage ) 30 minute post-analgesic administration . The primary outcome difference 2 group pain relief 30 minute . The secondary outcome side effect . We compare safety profile analgesic respect incidence hypotension , respiratory depression , nausea vomiting , pruritis , need opioid reversal agent ( naloxone ) , tachycardia , laryngospasm , hypersalivation , dizziness , agitation need benzodiazepine ( midazolam ) administration symptomatic evidence emergence reaction . All data enter analyzed via SPSS . Data analysis include frequency distribution , ANOVA ass difference pain score group various time point . All patient analyze intent treat analysis . However , subgroup analysis do emergence reaction event occur often .</detailed_description>
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>1 . ED patients1855 year old presenting moderate severe ( Numeric Pain Rating Score &gt; 5 ) acute ( le 7 day ) 2. abdominal , flank , back musculoskeletal pain warranting ( treat physician 's judgment ) administration intravenous opioid pain medication . 3 . Patients must awake , alert oriented time , place person , 4. patient must able demonstrate understanding informed consent . 5 . Patient must able verbalize much pain 10 point Numeric Rating Pain Scale , 6 . Patient mu able verbalize nature side effect may experience intravenous analgesia . 1 . Pregnancy breast feed 2 . SBP &lt; 90 3 . Weight great 115kg less 45kg , 4. alter mental status , 5. allergy ketamine morphine , 6. history acute head ocular trauma 7. presence intracranial mass vascular lesion , presence psychiatric history 8. diagnosis treatment ( assessed electronic chart review ) . 9. history seizure intracranial hypertension 10. history chronic pain , pain syndrome fibromyalgia 11. presence cardiovascular disease except control hypertension 12. history acute head ocular trauma , drug alcohol abuse precede 6 month 13. drug alcohol abuse precede 6 month 14 . SBP &gt; 180 15 . HR &lt; 50 16 . HR &gt; 150 17 . RR &lt; 10 18 . RR &gt; 30 19. administration opiate pain medication past 4 hour prior assessment ( i.e . home , EMS , triage , office , etc . ) 20. presence renal hepatic insufficiency ( assessed electronic chart review ) ,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>pain</keyword>
	<keyword>Ketamine</keyword>
	<keyword>Emergency Medicine</keyword>
	<keyword>morphine</keyword>
</DOC>